Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-11-15
2008-11-25
Li, Q. Janice (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C514S04400A
Reexamination Certificate
active
07456015
ABSTRACT:
A vector and a method are provided for delivering a nucleic acid to a nervous system cell. The vector includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system that includes a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method includes providing a recombinant adeno-associated viral (rAAV) vector and administering the vector to a nervous system cell. Expression of a product from the first nucleic acid is regulatable by the promoter system.
REFERENCES:
patent: 5770414 (1998-06-01), Gage et al.
patent: 6180613 (2001-01-01), Kaplitt et al.
patent: 6503888 (2003-01-01), Kaplitt et al.
patent: 6610290 (2003-08-01), Podsakoff et al.
patent: 6875568 (2005-04-01), Nisson et al.
patent: WO 2005/116224 (2005-12-01), None
Seq ID No. 25 search result.
Hasan et al., Genesis, 29: 116-122, 2001.
Jiang, L. et al.; “Quantitation of Transgene Expression from Self-regulating rAAV Vectors by Flow Cytometry;” American Society of Gene Therapy; Molecular Therapy vol. 5, May 2002, Part 2 of 2 Parts; © The American Society of Gene Therapy, S138; Abstract.
Jiang, L. et al.; “Quantitation of Transgene Expression from Self-regulating rAAV Vectors by Flow Cytometry;” Poster presented at American Society of Gene Therapy meeting on Jun. 6, 2002.
Lo et al., Hum. Gene Ther., 10: 201-213, 1999.
Xiao et al., J. Virol., 72: 2224-2232, 1998.
Xu et al., Gene Therapy, 5: 1323-1332, 2001.
Zolotukhin et al., Gene Therapy 6; 973-985, 1999.
Baron, U. et al.; “Tet Repressor-Based System for Regulated Gene Expression in Eukaryotic Cells: Principles and Advances;” Methods in Enzymology, vol. 327; 2000; pp. 401-421.
Baron, U. et al.; “Tetracycline-controlled transcription in eukaryotes : novel transactivators with graded transactivation potential;” Nucleic Acids Research; 1997; vol. 25, No. 14; pp. 2723-2729.
Berns and Bohenzky,Advances in Virus Research(Academic Press, Inc.) 32:243-307, 1987.
Blesch, A. et al.; “Neurite Outgrowth Can Be Modulated in Vitro Using a Tetracycline-Repressible Gene Therapy Vector Expressing Human Nerve Growth Factor;” Journal of Neuroscience Research 59;402-409 (2000).
Bohl et al.,Hum. Gene Ther., 8:195-204, 1997.
Chenaud, P. et al.; Mol. Ther. Mar. 2004; 9(3):410-8.
Choi-Lundberg, D.L. et al. Science, 275, 838-841, 1997.
Clark et al., Hum. Gene Ther., 10: 1031-1039, 1999.
Connor, B. et al.; “Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat;” Gene Therapy (1999) 6; 1936-1951; 1999.
Corti, O. et al.; “A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors;” Nature Biotechnology, vol. 17; Apr. 1999; pp. 349-354.
Eberling, J.L.;Mol. Ther., 8:873-875, 2003.
Fitzsimons, H.L. et al.; “Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain;” Gene Therapy (2001) 8, 1675-1691.
Flotte et al., J. Biol. Chem., 268: 3781-3790, 1993.
Gossen, M. et al.; “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters;” Proc. Natl. Acad. Sci. USA; vol. 89; pp. 5547-5551; Jun. 1992; Cell Biology.
Grimm et al.,Hum. Gene Ther., 9: 2745-2760, 1998.
Jiang, L. et al.; “Quantization of Transgene Expression from Self-regulation rAAV Vectors by Flow Cytometry;” American Society of Gene Therapy; http://www.marathonmultimedia.com/submission/ASGT/preview.pho?abs=450171; Abstract.
Jiang, L. et al.; “Self regulating rAAV vectors using a tetracycline (TET)—off promoter are tightly regulated in vitro and in vivo;” Society for Neuroscience Abstract Viewer and Itinerary Planner; vol. 2003, 2003, pages Abstract No. 79.19; 33rdAnnual Meeting of the Society of Neuroscience; New Orleans, LA, U.S.A.
Jiang, L. et al.; “Tight Regulation from a rAAV Vector as Demonstrated by Flow Cytometry and Quantitative RT-PCR;” Society for Neuroscience Abstract Viewer and Itinerary Planner; vol. 2002, 2002, pages Abstract No. 902.4; 32rdAnnual Meeting of the Society for Neuroscience; Orlando, Florida, U.S.A.; Nov. 2-7, 2002.
Jiang, L. et al.; “Tight Regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative real-time PCR;” Gene Therapy (2004) 11: pp. 1057-1067.
Kaludov et al., Hum. Gene Ther., 13: 1235-1243, 2002.
Kozak, M., Cell, 44(2):283-92, 1986.
Kozak, M, J. Biol. Chem., 266(30): 19867-19870, 1991.
Kozak, M. Nucleic Acids Res., Oct. 26;15(20):8125-48, 1987.
Kozak, M.; “Structural Features in Eudaryotic mRNAs That Modulate the Initiation of Translation;” The Journal of Biological Chemistry, vol. 266, No. 30, Issue of Oct. 25; pp. 19867-19870; 1991.
Kozlowski et al., Mol. Ther., 3: 256-261, 2001.
Muzyczka, (1992)Curr Topics Microbiol. Immunol. 158:97.
Peel et al., J. Neurosci. Methods, 98:95-104, 2004.
Sànchez-Pernaute, R. et al.; “Functional Effect of Adeno-associated Virus Mediated Gene Transfer of AromaticL-Amino Acid Decarboxylase into the Striatu of 6-OHDA-Lesioned Rats;” Molecular Therapy, vol. 4, Issue 4; Oct. 2001; pp. 324-330 (Abstract).
Urlinger, S. et al.; “Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity;”Proc. Natl. Acad. Sci. USA, 97: 7963-7968, 2000.
Veldwijk et al., Mol. Ther., 6: 272-278, 2002.
International Search Report dated Dec. 7, 2005 for International Application No. PCT/US2005/015612.
Bohn Martha C.
Jiang Lixin
Vanin Elio F.
West Neva C.
Brinks Hofer Gilson & Lione
Children's Memorial Hospital
Hill Kevin K.
Li Q. Janice
LandOfFree
Tetracycline-regulated adeno-associated viral (AAV) vectors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetracycline-regulated adeno-associated viral (AAV) vectors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracycline-regulated adeno-associated viral (AAV) vectors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4047829